论文部分内容阅读
目的:分析稳定期慢性阻塞性肺疾病长期服用羧甲司坦的效果。方法:随机选取医院收治的2013年3月至2015年3月50例稳定期慢性阻塞性肺疾病患者,并且依据随机数字表方法,分为研究组(25例)、对照组(25例)。给予对照组中患者,应用常规方法治疗干,研究组中患者,采取羧甲司坦治疗,对比两组患者疗效。结果:对于研究组中患者,临床经长期服用羧甲司坦治疗之后,明显改善患者疗效,患者肺功能、运动能力均优于对照组(P<0.05)。结论:在临床治疗稳定期慢性阻塞性肺疾病中,对患者长期服用羧甲司坦治疗,效果显著。
OBJECTIVE: To analyze the effect of long-term use of carbocisteine in patients with stable chronic obstructive pulmonary disease. Methods: Fifty patients with stable COPD from March 2013 to March 2015 were randomly selected and divided into study group (25 cases) and control group (25 cases) according to random number table method. The patients in the control group were treated with the conventional method to treat patients in the study group and the patients in the study group. Carboxyesttamide treatment was used to compare the efficacy of the two groups of patients. Results: For patients in the study group, clinical long-term use of carbetoltin treatment significantly improved the efficacy of patients with pulmonary function and exercise capacity were better than the control group (P <0.05). CONCLUSIONS: Long-term use of carbocisteine in patients with chronic obstructive pulmonary disease in stable clinical therapy has shown significant results.